Draft:Gareth Sheridan
| Submission declined on 13 July 2025 by Gheus (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 12 July 2025 by Snowycats (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Declined by Snowycats 24 days ago. | |
| Submission declined on 11 July 2025 by Qcne (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Declined by Qcne 25 days ago. | |
| Submission declined on 3 March 2025 by Gheus (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by Gheus 5 months ago. | |
| Submission declined on 4 September 2024 by Bobby Cohn (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. The content of this submission includes material that does not meet Wikipedia's minimum standard for inline citations. Please cite your sources using footnotes. For instructions on how to do this, please see Referencing for beginners. Thank you. Declined by Bobby Cohn 11 months ago. | |
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Gareth Sheridan (born c. 1990) is an Irish entrepreneur and the founder of Nutriband Inc., a pharmaceutical company listed on the NASDAQ stock exchange that develops transdermal drug delivery systems.[1]
Early life and education
[edit]Sheridan was born in Terenure, Dublin, Ireland.[1] He studied business and management at what is now Technological University Dublin, where he conceived the idea for Nutriband during his final year in 2012.[1]
Career
[edit]Sheridan founded Nutriband Ltd. in Dublin in 2012 while completing his studies.[1] The company initially focused on supplement delivery through transdermal patches. Recognizing the limitations of the Irish market, Sheridan established Nutriband Inc. in the United States with headquarters in Orlando, Florida.[1]
The company develops abuse-deterrent transdermal systems for opioid medications.[1] Nutriband's technology incorporates capsaicin and denatonium benzoate to deter misuse while maintaining effectiveness when used correctly.[1] The company went public on the NASDAQ stock exchange in October 2021 under the ticker symbol NTRB.[2]
Public commentary
[edit]In 2025, Sheridan emerged as a commentator on pharmaceutical policy and trade issues. His analysis was featured in major international publications including The Guardian and BBC, where he examined the potential impact of proposed tariffs on global pharmaceutical supply chains.[3][4]
Sheridan warned that tariffs on pharmaceutical imports could disrupt global supply chains and increase costs for patients. Speaking to the BBC, he stated that "these types of treatments can't afford a disruption in the global supply chain," drawing comparisons between pharmaceutical and automotive tariffs to illustrate the life-or-death nature of medication access.[4] His commentary was also featured in The Guardian[3] and The Business Post, where he warned that "ultimately, people will die" if pharmaceutical tariffs are implemented.[5]
Recognition
[edit]In 2014, Sheridan received the Bank of Ireland Start-up Awards "Best Young Entrepreneur" award and was named Ireland's "Young Entrepreneur of the Year."[6] Nutriband was also recognised with Ireland's "Best New Product" award that year.[6]
In 2025, Sheridan was named as a finalist in the EY Entrepreneur of the Year awards in the "Established" category, competing among 24 entrepreneurs whose companies collectively generate nearly €1 billion in revenues.[7]
Sheridan serves as an Entrepreneurial Ambassador for TU Dublin, providing guidance to students interested in innovation and entrepreneurship.[8]
References
[edit]- ^ a b c d e f g Ryan, Emmet (2025-02-20). "Irish entrepreneur aims to disrupt painkiller market and build multibillion-dollar business". The Irish Times. Retrieved 2025-07-12.
- ^ "WallachBeth Capital Announces Completion of a $6.6 Million Underwritten Public Offering for Nutriband Inc. (NASDAQ: NTRB) and Up-listing to the NASDAQ Capital Market". Nasdaq.com. 2021-10-06.
- ^ a b Kollewe, Julia (2025-05-05). "Americans would suffer most if Trump imposes pharma tariffs, sector warns". The Guardian. ISSN 0261-3077. Retrieved 2025-07-12.
- ^ a b "Trump announces tariffs on goods entering US from NI and Ireland". www.bbc.com. 2025-04-02. Retrieved 2025-07-12.
- ^ "'Ultimately, people will die': Irish pharma chief says tariff threat is acute for US medical patients". Business Post. 2025-03-28. Retrieved 2025-07-12.
- ^ a b Leogue, Joe (2015-07-09). "Dublin student to cash in as patch idea goes global". Irish Examiner. Retrieved 2025-07-12.
- ^ Dooley, Hugh (2025-04-17). "Shortlist for 2025 EY Entrepreneur of the Year awards revealed". The Irish Times. Retrieved 2025-07-12.
- ^ Dublin, T. U. "Entrepreneurial Ambassadors | Entrepreneurial Ambassadors Profiles | TU Dublin". www.tudublin.ie. Retrieved 2025-07-12.
- AfC submissions by date/12 July 2025
- AfC submissions by date/11 July 2025
- AfC submissions by date/20 February 2025
- AfC submissions by date/04 September 2024
- Draft articles on biographies
- Draft articles on Northern Europe
- Draft articles on business and economics
- Draft articles on STEM
- AfC submissions on living persons